218150 — Milae Bioresources Co Cashflow Statement
0.000.00%
- KR₩74bn
- KR₩75bn
- KR₩62bn
Annual cashflow statement for Milae Bioresources Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 953 | 1,079 | 878 | 359 | -420 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1,105 | 1,212 | 783 | -136 | 801 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,930 | -229 | -1,498 | 1,950 | -2,521 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 848 | 2,982 | 1,192 | 3,230 | -966 |
Capital Expenditures | -220 | -546 | -488 | -628 | -104 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -2,284 | -145 | -11,243 | -3,405 | 2,882 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,504 | -691 | -11,731 | -4,033 | 2,778 |
Financing Cash Flow Items | -136 | -27 | -7.32 | -2.91 | -100 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.9 | 13,027 | -61.9 | -4,767 | 1,024 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,654 | 15,338 | -10,597 | -5,560 | 2,843 |